| Guo, Wei |
NCT05250050: Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment |
|
|
| Recruiting | 4 | 388 | RoW | Esomeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 03/23 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
ALTN-III-04, NCT05121350: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma |
|
|
| Recruiting | 3 | 256 | RoW | Anlotinib hydrochloride capsule, Epirubicin, Arotinib hydrochloride capsule placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Soft Tissue Sarcoma | 06/24 | 06/24 | | |
| Active, not recruiting | 3 | 90 | Europe, Canada, US, RoW | Pimicotinib(ABSK021), Placebo | Abbisko Therapeutics Co, Ltd | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | 05/26 | 06/28 | | |
NCT04833036: c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI |
|
|
| Recruiting | 2 | 120 | RoW | Irinotecan, cetuximab | Fudan University | Colorectal Cancer | 01/22 | 11/22 | | |
MAPAC, NCT04351308: Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma |
|
|
| Recruiting | 2 | 60 | RoW | MAPI chemotherapy, Apatinib Mesylate, Camrelizumab | Peking University People's Hospital, Chinese Sarcoma Study Group | Osteosarcoma, Survival, Chemotherapy Effect, Toxicity, Drug | 09/22 | 12/22 | | |
| Recruiting | 2 | 60 | RoW | Vincristine, VCR, Temozolomide, Temodar | Peking University People's Hospital | Ewing Sarcoma | 11/22 | 02/25 | | |
AIEO, NCT04824352: Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma |
|
|
| Suspended | 2 | 44 | RoW | apatinib, IE chemotherapy | Peking University People's Hospital, Peking University Shougang Hospital | Effect of Drug, Toxicity, Drug | 04/26 | 04/26 | | |
NCT04582981: Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer |
|
|
| Recruiting | 2 | 136 | RoW | Fruquintinib and raltitrexed, F and R, Fruquintinib, F | Fudan University, Shanxi Province Cancer Hospital | Advanced Colorectal Carcinoma | 06/23 | 12/23 | | |
OAIE, NCT05277480: Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma |
|
|
| Completed | 2 | 81 | RoW | Apatinib+IE, IE | Peking University People's Hospital, Jiangsu HengRui Medicine Co., Ltd. | Effect of Drug, Drug, Toxicity | 06/23 | 11/23 | | |
| Not yet recruiting | 2 | 118 | RoW | TQB3616 capsule, TQB3616 placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Dedifferentiated Liposarcoma | 04/24 | 12/24 | | |
NCT05046314: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma |
|
|
| Recruiting | 2 | 30 | RoW | TK216+Vincristin | Shanghai Pharmaceuticals Holding Co., Ltd | Sarcoma, Ewing | 09/25 | 12/25 | | |
| Recruiting | 2 | 170 | RoW | HS-20093 | Hansoh BioMedical R&D Company | Osteosarcoma, Sarcoma | 12/25 | 12/27 | | |
| Active, not recruiting | 1/2 | 29 | RoW | TQB3525 | Peking University People's Hospital | Safety Issues, Efficacy, Self | 01/22 | 06/22 | | |
TQB2858-I-05, NCT05154630: Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors |
|
|
| Terminated | 1/2 | 8 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cancer, Advanced Soft-tissue Sarcoma | 03/23 | 06/23 | | |
NCT04448379: Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer |
|
|
| Recruiting | 1 | 48 | RoW | JMT101, Afatinib or Osimertinib | Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Locally Advanced or Metastatic Non-Small Cell Lung Cancer | 12/21 | 06/22 | | |
| Recruiting | 1 | 96 | US, RoW | GQ1001 | GeneQuantum Healthcare (Suzhou) Co., Ltd., Conjugate Light (Australia) Pty Ltd | HER2-positive Breast Cancer, HER2-positive Biliary Tract Cancer, HER2-Positive Salivary Gland Carcinomas, HER2-Positive Advanced Solid Tumor | 03/24 | 05/24 | | |
NCT03358628: Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma |
|
|
| Not yet recruiting | N/A | 20 | NA | Molecular Profiling & In Vivo drug testing in PDX | Peking University People's Hospital | Osteosarcoma | 01/20 | 01/25 | | |
NCT03360760: Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum |
|
|
| Recruiting | N/A | 100 | RoW | Doxorubicin, Adriamycin, Cisplatin, cisplatinum, platamin, Methotrexate, HD-MTX, Ifosfamide, ifosphamide, definitive surgery, pre surgical chemotherapy, neoadjuvant chemotherapy | Peking University People's Hospital | Osteosarcoma of Pelvis | 02/20 | 02/25 | | |
NCT03687489: Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System |
|
|
| Active, not recruiting | N/A | 156 | RoW | Abdominal Aortic Aneurysm Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Abdominal Aortic Aneurysm | 11/20 | 03/25 | | |
NCT04717661: A Diagnostic Test Study of Characteristic Sound Waves in Radial Artery of Early Pregnant Women |
|
|
| Recruiting | N/A | 152 | RoW | | Qianfoshan Hospital | Early Pregnancy, Radial Artery | 03/22 | 03/22 | | |
NCT04731636: Guo's Visceral Arteries Reconstruction: First in Man Study |
|
|
| Completed | N/A | 15 | RoW | Thoracoabdominal aortic stent system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm | 03/22 | 03/22 | | |
NCT04037982: RCT Study on Safety of LPD and OPD in the Treatment of Periampullary Tumors |
|
|
| Not yet recruiting | N/A | 102 | RoW | laparoscopic pancreaticoduodenectomy, Open pancreaticoduodenectomy | Beijing Friendship Hospital | Periampullary Tumor, Complication, Death, Survival | 12/22 | 12/22 | | |
NCT05179967: Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study) |
|
|
| Recruiting | N/A | 106 | RoW | WeFlow-JAAA Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Juxtarenal Abdominal Aortic Aneurysm | 12/22 | 12/23 | | |
NCT03455855: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA |
|
|
| Completed | N/A | 72 | RoW | Jetstream System | Boston Scientific Corporation | Atherosclerosis | 02/23 | 01/24 | | |
| Completed | N/A | 223 | RoW | Primary tumor resection or not | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, First Affiliated Hospital of Chongqing Medical University | Non-small-cell Lung Cancer (NSCLC) | 10/23 | 12/23 | | |
VR-TSP, NCT06574451: Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain |
|
|
| Recruiting | N/A | 215 | RoW | VR-assisted postoperative analgesia | Guangdong Provincial People's Hospital, Guang Dong Liang Zi Health Consulting Co., Ltd, Guang Dong, China., Tianjin Medical University General Hospital, Ruijin Hospital, Maoming People's Hospital | Acute Postoperative Pain, Video-assisted Thoracic Surgery, Virtual Reality | 04/25 | 04/25 | | |
RECOMMEND, NCT05587452: Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence |
|
|
| Recruiting | N/A | 950 | RoW | Colonoscopy, Test of ctDNA methylation, Test of characteristics of ctDNA fragment | Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Cangzhou Central Hospital, Weifang Medical University, Heji Hospital affiliated to Changzhi Medical College, Beijng Fengtai Hospital | Colorectal Adenoma, Colorectal Cancer | 05/23 | 05/25 | | |
NCT06478576: Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm |
|
|
| Recruiting | N/A | 73 | RoW | multibranched stent graft system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysm | 05/28 | 05/28 | | |
NCT05375123: Reference Range for Tissue Motion Tracking of Mitral Annulus Displacement in Chinese Han Singleton Pregnancies |
|
|
| Recruiting | N/A | 660 | RoW | Ultrasound image acquisition | First Hospital of China Medical University | Pregnancy | 06/23 | 06/24 | | |
NCT05547841: Normal Reference Value for Echocardiography in Chinese Han Pregnancies |
|
|
| Recruiting | N/A | 680 | RoW | Echocardiography acquisition | First Hospital of China Medical University | Pregnancy | 08/23 | 08/24 | | |
NCT05803564: Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm. |
|
|
| Recruiting | N/A | 46 | RoW | Thoracoabdominal aortic stent system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal; Aortic, Aneurysm, Dissecting | 11/26 | 10/27 | | |
| Recruiting | N/A | 190 | RoW | Endoscopic surgery, Suboccipital craniotomy surgery | Tang-Du Hospital | Posterior Fossa Hemorrhage | 12/23 | 12/24 | | |
NCT04745039: Guo's Entry Tear Repair :The First in Man Study of Endopatch System |
|
|
| Recruiting | N/A | 27 | RoW | Endopatch System | Hangzhou Endonom Medtech Co., Ltd. | Chronic Stanford B Type Aortic Dissection Proximal Tear | 12/23 | 12/23 | | |
NCT03899350: The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage |
|
|
| Recruiting | N/A | 1000 | RoW | No intervention | Tang-Du Hospital | Spontaneous Intracranial Hemorrhage, Spontaneous Intraparenchymal Cerebral Hemorrhage, Spontaneous Cerebellar Haemorrhage | 12/23 | 12/25 | | |
GRAFT, NCT05754541: Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study( Study) |
|
|
| Recruiting | N/A | 20 | RoW | WeFlow-Tribranch Aortic Arch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Aneurysm and Dissection | 12/23 | 12/25 | | |
NCT04764370: Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System |
|
|
| Completed | N/A | 8 | RoW | WeFlow-Ach Moduler Embedded Branch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch; Aneurysm, Dissecting | 10/22 | 10/22 | | |
| Recruiting | N/A | 400 | RoW | Goal-directed EN therapy, Conventional EN therapy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Esophagus Cancer | 08/26 | 05/31 | | |
GENIUS, NCT04849325: IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease |
|
|
| Recruiting | N/A | 120 | RoW | Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titanâ„¢), Percutaneous Transluminal Angioplasty (PTA) Device | Biotyx Medical (Shenzhen) Co., Ltd. | Critical Limb Ischemia (CLI) | 04/24 | 10/24 | | |
NCT06071403: The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants |
|
|
| Recruiting | N/A | 416 | RoW | (enteral feeding volume/ total fluid volume)*100% | Peking University | Growth Retardation | 06/24 | 09/26 | | |
NCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) |
|
|
| Recruiting | N/A | 90 | RoW | WeFlow-Tribranch embedded aortic Triple-branch arch Stent Graft system | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 12/25 | 12/30 | | |
NCT04982367: Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis |
|
|
| Recruiting | N/A | 166 | RoW | Sirolimus-eluting balloon catheter, Sirolimus coated balloon catheter, Paclitaxel-eluting balloon catheter, Paclitaxel coated balloon catheter | Acotec Scientific Co., Ltd | Peripheral Artery Disease | 07/24 | 07/24 | | |
NCT06605209: Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT) |
|
|
| Recruiting | N/A | 130 | RoW | Peripheral Balloon-Expandable Covered Stent System | Zhejiang Zylox Medical Device Co., Ltd. | Peripheral Artery Disease (PAD) | 07/26 | 12/26 | | |
NCT05246410: A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. |
|
|
| Recruiting | N/A | 196 | RoW | Spot stent system, Self-expanding peripheral stent system | Acotec Scientific Co., Ltd | Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD) | 11/24 | 12/24 | | |
NCT05054985: Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm. |
|
|
| Recruiting | N/A | 73 | RoW | Multi-Branched Thoracoabdominal Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysms | 12/24 | 12/28 | | |
NCT05662618: To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease |
|
|
| Not yet recruiting | N/A | 276 | RoW | Percutaneous selective arteriography of peripheral arteries | Shanghai Bomaian Medical Technology Co., Ltd | Peripheral Arterial Disease | 06/25 | 06/25 | | |
NCT04765605: Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study) |
|
|
| Active, not recruiting | N/A | 120 | RoW | WeFlow-Tbranch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Type B Aortic Dissection | 12/26 | 12/26 | | |
NCT06062524: Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System |
|
|
| Recruiting | N/A | 20 | RoW | Aorta Vascular Plug System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Dissection Aneurysm | 05/26 | 05/26 | | |
NCT04861883: A Diagnostic Test Study of Characteristic Sound Waves in the Middle and Third Trimester of Pregnancy Women |
|
|
| Recruiting | N/A | 152 | RoW | | Qianfoshan Hospital | Pregnancy, Radial Artery | 03/22 | 03/22 | | |
NCT05513664: Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer |
|
|
| Not yet recruiting | N/A | 80 | RoW | Osimertinib | Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Locally Advanced or Metastatic Non-Small Cell Lung Cancer, EGFR Exon20 Insertion Mutations | 06/23 | 08/23 | | |
| Qu, Yan |
| Recruiting | 2 | 168 | RoW | Propranolol Hydrochloride, control group | Beijing Tiantan Hospital | Stroke, Vascular Accident, Intracranial Hemorrhages, Intracerebral Hemorrhage, Hemorrhagic Stroke, Stroke, Acute | 07/24 | 07/25 | | |
| Not yet recruiting | 2 | 100 | NA | Baricitinib 4 MG, JAK Inhibitor, Standard treatment | Tang-Du Hospital | Spontaneous Subarachnoid Hemorrhage | 12/26 | 06/27 | | |
NCT06065046: Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions |
|
|
| Not yet recruiting | 2 | 100 | RoW | Baricitinib 4 MG, Baricitinib, Standard treatment, Blank control | Tang-Du Hospital | Traumatic Brain Injury | 07/25 | 12/25 | | |
| Not yet recruiting | 1/2 | 40 | NA | Fingolimod | Tang-Du Hospital | Intracerebral Hemorrhage | 06/25 | 12/25 | | |
NCT05892653: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors |
|
|
| Terminated | 1 | 15 | RoW | ABM-1310 | ABM Therapeutics Shanghai Company Limited | Primary Malignant Brain Tumor | 08/24 | 08/24 | | |
NCT05279599: Application of Circulating Extracellular Vesicles in Early Disease Assessment and Prognosis After Traumatic Brain Injury |
|
|
| Recruiting | N/A | 300 | RoW | | Tang-Du Hospital | Traumatic Brain Injury | 11/22 | 11/22 | | |
| Recruiting | N/A | 190 | RoW | Endoscopic surgery, Suboccipital craniotomy surgery | Tang-Du Hospital | Posterior Fossa Hemorrhage | 12/23 | 12/24 | | |
NCT03899350: The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage |
|
|
| Recruiting | N/A | 1000 | RoW | No intervention | Tang-Du Hospital | Spontaneous Intracranial Hemorrhage, Spontaneous Intraparenchymal Cerebral Hemorrhage, Spontaneous Cerebellar Haemorrhage | 12/23 | 12/25 | | |
| Not yet recruiting | N/A | 240 | NA | | Tang-Du Hospital | Traumatic Brain Injury | 07/25 | 12/25 | | |
NCT05035134: Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 300 | RoW | | Tang-Du Hospital | Intracerebral Hemorrhage；Circulating Exosomes | 07/22 | 07/22 | | |
| Liu, Haixiao |
| Recruiting | N/A | 190 | RoW | Endoscopic surgery, Suboccipital craniotomy surgery | Tang-Du Hospital | Posterior Fossa Hemorrhage | 12/23 | 12/24 | | |
NCT03899350: The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage |
|
|
| Recruiting | N/A | 1000 | RoW | No intervention | Tang-Du Hospital | Spontaneous Intracranial Hemorrhage, Spontaneous Intraparenchymal Cerebral Hemorrhage, Spontaneous Cerebellar Haemorrhage | 12/23 | 12/25 | | |
| Ge, Shunnan |
NCT06065046: Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions |
|
|
| Not yet recruiting | 2 | 100 | RoW | Baricitinib 4 MG, Baricitinib, Standard treatment, Blank control | Tang-Du Hospital | Traumatic Brain Injury | 07/25 | 12/25 | | |
| Wu, Xun |
NCT05035134: Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 300 | RoW | | Tang-Du Hospital | Intracerebral Hemorrhage；Circulating Exosomes | 07/22 | 07/22 | | |
| Hu, Qing |
NCT05279599: Application of Circulating Extracellular Vesicles in Early Disease Assessment and Prognosis After Traumatic Brain Injury |
|
|
| Recruiting | N/A | 300 | RoW | | Tang-Du Hospital | Traumatic Brain Injury | 11/22 | 11/22 | | |
BIATICH, NCT05593380: The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH |
|
|
| Recruiting | N/A | 190 | RoW | Parenchymal Intracranial pressure monitor, Integra Life Sciences Camino Intracranial Monitor, Treatment based on clinical and imaging observations | Xiangya Hospital of Central South University | Cerebral Hemorrhage, Hypertensive, Intracranial Hypertension, Monitoring, Critical Care, Treatment Outcome, Invasive Intracranial Pressure Monitoring, Large-volume Cerebral Hemorrhage | 12/24 | 03/25 | | |
